Trials / Unknown
UnknownNCT02784847
A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University of Liege · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A pilot trial of triheptanoin, a natural compound able to promote anaplerotic mitochondrial metabolism, for the preventative treatment of migraine.
Detailed description
To test the ability of a daily 3-month treatment with triheptanoin to prevent migraine attacks in 10 migraine patients. This is an open, non-randomized pilot trial that might justify a placebo-controlled trial, if there are at least 50% of patients with ≥50% reduction in attack frequency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triheptanoin | Triheptanoin oil administered three times per day during meals at a total dose 1mg/kg/day for 3 months |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2016-05-27
- Last updated
- 2016-05-27
Source: ClinicalTrials.gov record NCT02784847. Inclusion in this directory is not an endorsement.